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IS SERUM LEVEL OF 25-HYDROXYVITAMIN D ASSOCIATED WITH THE
RISK OF HIP REPLACEMENT FOR OSTEOARTHRITIS? RESULTS FROM
A PROSPECTIVE COHORT STUDY
S. Hussain y, R. Daly z, Y. Wang y, J. Shaw x, D. Magliano x, S. Graves k,
P. Ebeling y, A. Wluka y, F. Cicuttini y. yMonash Univ., Melbourne,
Australia; zDeakin Univ., Melbourne, Australia; xBaker IDI Heart and
Diabetes Inst., Melbourne, Australia; kUniv. of Adelaide, Adelaide, Australia
Purpose: Evidence is conﬂicting for the association between serum 25-
hydroxy-vitamin D[25(OH)D] concentrations and risk of hip osteo-
arthritis. The aim of this prospective cohort study was to determine
whether serum 25(OH)D concentrations were associated with the
incidence of hip replacement for osteoarthritis.
Methods: This study examined 9,135 participants from the Australian
Diabetes, Obesity and Lifestyle Study who had serum 25(OH)D meas-
ured in 1999-2000 and were aged 40 years at the commencement of
hip replacement data collection. The incidence of hip replacement for
osteoarthritis during 2002-2011 was determined by linking cohort
records to the Australian Orthopaedic Association National Joint
Replacement Registry. The association between serum 25(OH)D and
incidence of hip replacement for osteoarthritis was estimated by hazard
ratio [HR, 95% conﬁdence interval (CI)] with age as the time-scale. Since
a sex interaction was identiﬁed, all analyses were stratiﬁed by sex and
adjusted for body mass index, smoking status, ethnicity, physical
activity, season of blood collection, latitude, area-level disadvantage,
diabetic status and hypertension.
Results: Over an average 9.1 (SD 2.7) years of follow-up, 90 males and
111 females had hip replacements for osteoarthritis. In males, a one SD
increase in 25(OH)D concentrations was associated with a 25%
increased incidence of hip replacement for osteoarthritis (HR 1.25, 95%
CI 1.02, 1.56), with a dose response relationship observed by quartiles of
25(OH)D concentration (P for trend 0.04). No signiﬁcant associationwasClinical and functional comparison between subgroups with and without foot pain
No foot pain
(n¼938)
Foot pain (n¼317) P* Ipsilateral foot
pain (n¼87)
Contralateral foot
pain (n¼56)
Bilateral foot pain
(n¼174)
P*
Depression, CES-D score 5.0 (-3.0-13.0) 6.0 (-3.0-15.0) y 0.007 7.0 (-3.0-17.0) 5.0 (-3.8-13.8) 6.0 (-4.0-16.0) y 0.002
SF-12 Mental Score 56.3 (46.6-66.1) 54.6 (42.4-66.8) y 0.017 54.4 (41.0-67.8) 54.9 (45.3-64.4) 54.4 (42.1-66.6) y 0.019
SF-12 Physical Score 47.3 (34.5-60.1) 43.5 (27.7-59.2) y <0.001 41.6 (23.1-60.0) y 48.9 (37.1-60.7) 42.6 (27.0-58.2) y <0.001
WOMAC Pain 5.0 (-1.0-11.0) 6.0 (0.3-11.6) y <0.001 7.0 (3.0-11.0) y 6.0 (0.0-12.0) 7.0 (1.0-13.0) y <0.001
WOMAC Stiffness 3.0 (1.0-5.0) 3.0 (0.0-6.0) y 0.003 4.0 (1.0-7.0) y 2.5 (0.5-4.5) 4.0 (1.0-7.0) y 0.012
WOMAC Function 14.9 (-2.5-32.3) 20.2 (-1.7-42.1) y <0.001 20.2 (-2.7-43.1) 20.1 (-0.2-40.4) 21.0 (-0.5-42.5) y <0.001
WOMAC Total 22.0 (-1.0-45.0) 30.6 (0.7-60.5) y <0.001 31.0 (2.1-59.9) 28.5 (-0.9-57.9) 32.0 (2.0-62.0) y <0.001
20m walk pace, m/s 1.30 (1.03-1.57) 1.24 (0.96-1.52) y 0.024 1.22 (0.99-1.46) y 1.29 (0.94-1.64) 1.25 (0.94-1.55) 0.019
Repeated chair stand
pace, stand/s
0.46 (0.29-0.63) 0.42 (0.23-0.61) 0.057 0.40 (0.23-0.57) y 0.46 (0.24-0.68) 0.42 (0.24-0.61) 0.014
CES-D ¼ Centre for Epidemiologic Studies Depression Scale; SF-12 ¼ Short Form-12; WOMAC ¼ Western Ontario and McMaster Universities Osteoarthritis Index.
* Signiﬁcance of MANCOVA between the foot pain and no foot pain groups, and between foot pain subgroups and the no foot pain group, adjusted for age, gender, BMI, KL
grade and co-morbidities.
y Signiﬁcantly different to no foot pain group.observed in females (HR 1.10 per SD increase in 25(OH)D concen-
trations, 95% CI 0.87, 1.39).
Conclusions: Higher serum 25(OH)D concentrations were associated
with an increased risk of hip replacement for osteoarthritis in males,
but not in females. The mechanism for the association warrants further
investigation.
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THE PREVALENCE AND IMPACT OF FOOT PAIN IN PEOPLE WITH
KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS
INITIATIVE
K.L. Paterson y, R.S. Hinman y, D.J. Hunter z, T.V. Wrigley y, K.L. Bennell y.
y The Univ. of Melbourne, Carlton, Australia; zUniv. of Sydney, Sydney,
Australia
Purpose: Knee osteoarthritis is a highly prevalent condition that
adversely affects function and quality of life. Foot pain is also common
and disabling, and therefore concurrent foot pain in people with knee
OA may further exacerbate disability and symptom severity than ifknee OA occurred in isolation. The aim of this study is to document
the prevalence of foot pain and foot pain laterality in people with
knee osteoarthritis (OA), and to examine its impact on health and
function.
Methods: Participants from the Progression subcohort (n¼1255, aged
45-79 years) of the Osteoarthritis Initiative with symptomatic tibiofe-
moral knee OAwere included. Prevalence of foot pain, deﬁned as pain in
the foot/ankle, and foot pain laterality referenced to the most affected
knee, was determined. Health status was evaluated using the Western
Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the
Short Form-12 (SF-12) and the Centre for Epidemiological Studies
Depression (CES-D) Scale. Function was assessed using the 20-meter
walk test (20MWT) and a repeated chair stand test. Differences in
health and functional measures were compared between groups with
and without foot pain using multivariate analysis of covariance
adjusting for age, gender, BMI, KL grade and co-morbidities. All data for
these analyses are from the OAI public use data sets.
Results: One quarter (n¼317, 25%) of people with knee OA experienced
concurrent foot pain and these people scored worse on all health
measures and on the 20MWT compared to those without foot pain
(p<0.05) (Table 1). Subgroup analyses revealed the majority experi-
enced pain in both feet (n¼174, 55%) or in the ipsilateral foot (n¼87,
27%). People with bilateral foot pain reported a signiﬁcantly higher CES-
D score (p<0.015), worse SF-12 mental (P¼0.017) and physical
(P<0.001) component scale scores and poorer scores on all WOMAC
subscales (p<0.01) compared to the no foot pain group. Furthermore,
the ipsilateral foot pain subgroup reported signiﬁcantly worse SF-12
physical scores (p¼0.004), higher WOMAC pain (p¼0.029) and stiffness
(p¼0.017) scores, walked signiﬁcantly more slowly (p¼0.049) and
performed signiﬁcantly slower on the repeated chair stand test
(p¼0.042) compared to people without foot pain. No differences were
found between the contralateral foot pain subgroup compared to the no
foot pain group on any of the measures.Conclusions: These ﬁndings show that foot pain is common in people
with knee OA, and bilateral and ipsilateral foot pain adversely affects
health and function suggesting laterality is important. Further research
is needed to establish the mechanism and interaction of pathology at
these sites, and to evaluate foot pain treatment in this population.
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IS KNEE ALIGNMENT AND MORPHOLOGY ASSOCIATED WITH
PATELLOFEMORAL OSTEOARTHRITIS? A SYSTEMATIC REVIEW
E.M. Macri y,z, J.J. Stefanik x, K.M. Khan y,z, K.M. Crossley k. yDept. of
Family Practice, Univ. of British Columbia, Vancouver, BC, Canada; zCtr.
for Hip Hlth.and Mobility, Univ. of British Columbia, Vancouver, BC,
Canada; xDept. of Physical Therapy and Athletic Training, Boston Univ.,
Boston, MA, USA; k Sch. of Hlth.and Rehabilitation Sci., Univ. of
Queensland, Brisbane, Australia
Purpose: Osteoarthritis (OA) affecting the patellofemoral (PF) joint is
strongly associated with pain and impaired function, and isolated PFOA
may progress towards multi-compartment knee OA. Abnormal loading
